Ken O'Flynn

596. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration further to Parliamentary Question No. 591 of 30 June 2026, which did not address the specific matter raised regarding representations made (details supplied); if his Department received correspondence or a meeting request from or on behalf of this organisation; if so, the date on which it was received; the reason no response has issued to date; and when a response can be expected. [51618/26]

674. Deputy Ken O'Flynn asked the Minister for Children, Disability and Equality further to Parliamentary Question No. 704 of 30 June 2026, in which her Department confirmed that permanency planning data is recorded in individual care plans but is not collated or reported nationally by Tusla; the reason no national system exists to aggregate this data given its centrality to the welfare of children in care; whether the development of a national permanency data system is being considered as part of the National Policy Framework for Alternative Care; and the timeline for any such system being put in place. [51619/26]

718. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2214 of 9 June 2026, to confirm the number of on-site audits of agency staffing suppliers conducted by the HSE in each of the years 2020, 2021, 2022, 2023 and 2024 individually, given that the reply addressed the year 2025 only; the precise number of instances of non-compliance identified across the six on-site audits conducted in 2025, given that the reply supplied no figure; whether those instances of non-compliance related to legislative obligations as distinct from the "non-legislative standards" referenced in the reply; if so, the number and nature of same; the proportion of the total national supplier panel represented by the "main suppliers" audited in 2025; and if she will make a statement on the matter. [50898/26]

720. Deputy Ken O'Flynn asked the Minister for Health if any single national system enables the HSE to identify, across all HSE-funded sites, if a healthcare worker, whether directly employed, agency or locum, who is currently on administrative leave or has been removed from placement, is subject to a criminal investigation or an unresolved patient-safety concern. [50918/26]

731. Deputy Ken O'Flynn asked the Minister for Health to confirm, in respect of the treatment abroad scheme, whether the public spending code applies to individual funding decisions and to programme-level oversight of the scheme; if not, the framework under which her Department satisfies itself that expenditure under the scheme meets the standards of regularity, propriety and value-for-money required of public funds; and if she will make a statement on the matter. [50968/26]

732. Deputy Ken O'Flynn asked the Minister for Health if a formal national policy or governance framework, as distinct from administrative processing arrangements, governs the authorisation, funding and oversight of the treatment abroad scheme; if such a framework exists, to provide a copy or web reference; and if no such framework exists, to confirm this explicitly. [50970/26]

733. Deputy Ken O'Flynn asked the Minister for Health if a clinical outcome data is recorded in respect of patients funded under the treatment abroad scheme following the completion of treatment abroad; and if no outcome data is recorded, to confirm this explicitly and the way in which her Department assesses the clinical effectiveness of expenditure under the scheme. [50972/26]

734. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a register of high-cost treatment abroad scheme approvals; if such a register is maintained, to state the monetary threshold or criteria used to classify a case as high-cost; and if no such register exists, to confirm this explicitly, in tabular form. [50974/26]

737. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Questions Nos. 2332 and 2333 of 9 June 2026, whether she is satisfied that the National Ambulance Service maintains no national dataset recording the elapsed time between receipt of a 999 call and allocation of an ambulance resource; whether she has requested that such a dataset be established; and if she will make a statement on the matter. [50977/26]

738. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2334 of 9 June 2026, whether she will now commission a national analysis examining the relationship between ambulance allocation or dispatch delays and mortality, morbidity, clinical deterioration or other patient outcomes; and if not, the basis on which she is satisfied that no such analysis is required. [50978/26]

739. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2330 of 9 June 2026, the recommendations, corrective actions, policy changes or service improvements that arose from the two system analysis reviews identified by the National Ambulance Service as involving ambulance allocation or dispatch delays since 2020; and the date on which each such action was implemented. [50979/26]

740. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2335 of 9 June 2026, whether she will publish the two system analysis reviews identified by the National Ambulance Service as having found ambulance allocation or dispatch delays to be contributory factors; and if publication is not possible, the specific findings, recommendations and corrective actions arising from each review. [50980/26]

741. Deputy Ken O'Flynn asked the Minister for Health further to the reply to Parliamentary Question No. 1010 of 16 June 2026, to specify each performance indicator currently used to measure the effectiveness of national obesity policy and obesity treatment services; and to provide the most recent result available for each such indicator. [50981/26]

742. Deputy Ken O'Flynn asked the Minister for Health further to the reply to Parliamentary Question No. 1011 of 16 June 2026, whether a costed implementation plan exists for the national model of care for obesity; the estimated total funding required for full implementation; the funding allocated to date; and if she will make a statement on the matter. [50982/26]

743. Deputy Ken O'Flynn asked the Minister for Health given that the obesity policy and action plan covers the period 2016 to 2025, the policy or framework that will succeed it from 2026; whether such successor policy has been adopted; and the date of its publication. [50983/26]

744. Deputy Ken O'Flynn asked the Minister for Health further to previous parliamentary questions on national targets for reducing obesity-attributable type 2 diabetes and cardiovascular disease incidence, whether the next obesity policy and action plan will contain the measurable targets for reducing the incidence of obesity-attributable type 2 diabetes and cardiovascular disease, as distinct from population overweight and obesity prevalence targets; whether her Department holds, or can access, national incidence data for obesity-attributable type 2 diabetes and cardiovascular disease sufficient to set a baseline against which such targets could be measured; the status of the prevalence targets contained in the 2016 plan (details supplied) including whether either was achieved; and given that both the 2016 plan and the healthy Ireland framework expired in 2025, the precise publication date for the successor plan and the policy basis on which obesity is being addressed in the interim; and if she will make a statement on the matter. [50989/26]

751. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2792 of 14 April 2026, the number of instances since July 2025 in which a health region exceeded its agency expenditure limit; and the corrective action taken in each such instance, by region. [51031/26]

752. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1079 of 6 May 2026, which confirmed that no formal cost-benefit analysis comparing long-term direct employment with agency staffing has been conducted, and that the only comparator in use is a generic 30% premium which by her Department's own account excludes pension provisions over an employee's career; if her Department intends to commission a full lifecycle cost-benefit analysis; and if not, the reason. [51032/26]

753. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1083 of 6 June 2026, to confirm whether the HSE holds any grade-specific cost comparison between agency and directly employed staff for nursing, medical and allied health grades respectively; if so, to provide same; and if not, the reason a single blended premium is applied across distinct grade markets. [51033/26]

754. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2314 of 9 June 2026, and noting that the same reply confirms health regions hold autonomy to reconfigure vacancies, whether any national assessment has been undertaken of the number of funded posts left unfilled or reconfigured as a result of agency spend limits; and whether any such risk is recorded on a national risk register. [51034/26]

755. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, to provide the data on the number of pharmacy reimbursement claims adjusted and the number successfully appealed in each year from 2020 to date (details supplied).; and if she will make a statement on the matter. [51052/26]

756. Deputy Ken O'Flynn asked the Minister for Health whether the Primary Care Reimbursement Service holds a national dataset recording the number of pharmacy reimbursement claims adjusted and the number successfully appealed; and if no such dataset is held, to state this plainly; and if she will make a statement on the matter. [51053/26]

757. Deputy Ken O'Flynn asked the Minister for Health to set out the formal mechanism, if any, by which a pharmacy may appeal a rejected reimbursement claim; the average time to determination; the number and proportion of such appeals upheld in each year from 2020 to date; and if she will make a statement on the matter. [51054/26]

758. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, to reconcile the figures provided in the reply, given that the difference between claims submitted (details supplied); and if she will make a statement on the matter. [51055/26]

759. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, recording "eligibility expired" as the leading reason for pharmacy claim rejection in the years 2020 to 2022, peaking at 30,005 rejections in 2021; the assessment that has been made of the impact on patients dispensed medicines whose eligibility had lapsed at point of dispensing, including whether any such patients were charged; and if she will make a statement on the matter. [51056/26]